01—Abstract
Summary
Summary of the 10-K filed February 7, 2024. Cited figures are marked; the original filing is the authoritative source.
3M Company's 2023 10-K filing reveals a challenging year marked by significant litigation charges that resulted in a net loss for the period, contrasting with the prior year's net income.
The company incurred substantial pre-tax charges totaling approximately $15.2 billiona related to the Public Water Systems (PWS) Settlement and the Combat Arms Earplugs (CAE) Settlement. Operationally, 3M experienced a sales decline of 4.5% to $32.7 billion, with organic sales down 3.2%. All four business segments—Safety and Industrial, Transportation and Electronics, Health Care, and Consumer—saw declines in net sales.
The company continues its strategic move to spin off its Health Care business, expected in the first half of 2024, which it believes will position both entities for future growth. Despite the operational challenges and legal headwinds, 3M maintained its commitment to returning capital to shareholders, with dividend increases and share repurchases. The company also provided an outlook for increased pension and postretirement expense in 2024.
02—Key points
Key Highlights
- 3M reported a net loss of $6.995 billion in 2023, primarily due to significant litigation charges related to the PWS Settlement ($10.5 billion pre-tax) and CAE Settlement ($4.3 billion pre-tax), totaling $15.2 billion in pre-tax charges.
- Total net sales decreased by 4.5% to $32.681 billion in 2023, with organic sales down 3.2%.
- All four business segments (Safety and Industrial, Transportation and Electronics, Health Care, Consumer) experienced sales declines.
- The planned spin-off of the Health Care business is anticipated to be completed in the first half of 2024.
- The company's financial health remains supported by a strong liquidity profile, with $6.0 billion in cash, cash equivalents, and marketable securities at year-end 2023, and a reduced net debt of $10.0 billion.
- 3M announced a 1% increase in its quarterly dividend to $1.51 per share for Q1 2024, demonstrating continued commitment to shareholder returns.
- The company is exiting all PFAS manufacturing by the end of 2025 and discontinuing the use of PFAS across its product portfolio by the end of 2025.
03—One dollar
Follow one dollar
For each $1.00 of revenue in FY2023, 3M Co lost $0.28.
- Revenue$24.61B100.0%
- Cost of revenue−$14.98B60.9%
- Gross profit$9.63B39.1%
- Operating costs−$20.32B82.6%
- Operating income−$10.69B43.4%
- Interest, other & tax$3.69B15.0%
- Net income−$7.00B28.4%
04—Financials
Financial Highlights
Figures from 10-KFY2023filed February 7, 2024Financial Statements
FY2023 against FY2022
| Line item | FY2023FY2022 | Change |
|---|---|---|
| Revenue | $24.61B$26.16B | −5.9% |
| Cost of Revenue | $14.98B$15.85B | −5.5% |
| Gross Profit | $9.63B$10.31B | −6.6% |
| R&D Expenses | $700.00M$800.00M | −12.5% |
| SG&A Expenses | $19.20B$7.23B | +165.5% |
| Operating Expenses | $35.30B$21.79B | +62.0% |
| Operating Income | -$10.69B$4.37B | −344.7% |
| Interest Expense | $942.00M$462.00M | +103.9% |
| Net Income | -$7.00B$5.78B | −221.1% |
| EPS (Basic) | $-12.63$10.21 | −223.7% |
| EPS (Diluted) | $-12.63$10.18 | −224.1% |
| Shares Outstanding (Basic) | 553.90M566.00M | −2.1% |
| Shares Outstanding (Diluted) | 553.90M567.60M | −2.4% |
05—Questions
Frequently Asked Questions
What were the primary drivers of 3M's financial performance in 2023?
The primary drivers were significant litigation charges related to the PWS Settlement and CAE Settlement, which resulted in a substantial pre-tax charge of $15.2 billion and led to a net loss for the year. Operationally, the company faced declining sales across all its segments due to various market factors.
What is the status of the Health Care business spin-off?
3M announced its intention to spin off its Health Care business as a separate public company. The transaction is expected to be completed in the first half of 2024, subject to customary conditions and regulatory approvals.
What is 3M's exposure to PFAS-related litigation and operational changes?
3M has incurred significant charges related to PFAS litigation settlements, including the PWS Settlement ($10.5-$12.5 billion) and CAE Settlement ($6.0 billion). The company is also actively exiting all PFAS manufacturing and discontinuing the use of PFAS across its product portfolio by the end of 2025, which involves ongoing costs and potential impacts on certain product lines.
How is 3M managing its debt and liquidity?
3M maintains a strong liquidity position with $6.0 billion in cash, cash equivalents, and marketable securities. The company's net debt decreased by $1.994 billion to $10.0 billion in 2023. The company has a $4.25 billion revolving credit facility and has access to capital markets, though its credit ratings have been impacted by the litigation settlements.
06—Continue